489 related articles for article (PubMed ID: 35326690)
1. Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.
Sellner F; Thalhammer S; Klimpfinger M
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326690
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.
Sellner F; Compérat E; Klimpfinger M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003482
[TBL] [Abstract][Full Text] [Related]
3. Isolated Pancreatic Metastases of Renal Cell Carcinoma-Clinical Particularities and Seed and Soil Hypothesis.
Sellner F; Thalhammer S; Klimpfinger M
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672289
[TBL] [Abstract][Full Text] [Related]
4. Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma.
Sellner F; Thalhammer S; Klimpfinger M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809634
[TBL] [Abstract][Full Text] [Related]
5. Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism?
Sellner F
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31533220
[TBL] [Abstract][Full Text] [Related]
6. Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?
Sellner F
Clin Exp Metastasis; 2018 Mar; 35(3):91-102. PubMed ID: 29948649
[TBL] [Abstract][Full Text] [Related]
7. Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations.
Sellner F
Front Oncol; 2020; 10():709. PubMed ID: 32547940
[TBL] [Abstract][Full Text] [Related]
8. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract][Full Text] [Related]
9. Metachronous isolated locally advanced pancreatic metastasis from chromophobe renal cell carcinoma.
Ayari Y; Ben Rhouma S; Boussaffa H; Chelly B; Hamza K; Sellami A; Jrad M; Nouira Y
Int J Surg Case Rep; 2019; 60():196-199. PubMed ID: 31233964
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
Kalra S; Atkinson BJ; Matrana MR; Matin SF; Wood CG; Karam JA; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
BJU Int; 2016 May; 117(5):761-5. PubMed ID: 26032863
[TBL] [Abstract][Full Text] [Related]
11. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma.
da Costa WH; Fares AF; Bezerra SM; Morini MA; de Toledo Benigno LA; Clavijo DA; Fornazieri L; Rocha MM; da Cunha IW; de Cassio Zequi S
Urol Oncol; 2019 Jan; 37(1):78-85. PubMed ID: 30446457
[TBL] [Abstract][Full Text] [Related]
12. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.
Kapur P; Peña-Llopis S; Christie A; Zhrebker L; Pavía-Jiménez A; Rathmell WK; Xie XJ; Brugarolas J
Lancet Oncol; 2013 Feb; 14(2):159-167. PubMed ID: 23333114
[TBL] [Abstract][Full Text] [Related]
13. Commentary on "Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation." Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. Lancet Oncol 2013; 14(2):159-67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.
Boorjian S
Urol Oncol; 2014 Aug; 32(6):934-5. PubMed ID: 25087671
[TBL] [Abstract][Full Text] [Related]
14. Modeling Renal Cell Carcinoma in Mice:
Gu YF; Cohn S; Christie A; McKenzie T; Wolff N; Do QN; Madhuranthakam AJ; Pedrosa I; Wang T; Dey A; Busslinger M; Xie XJ; Hammer RE; McKay RM; Kapur P; Brugarolas J
Cancer Discov; 2017 Aug; 7(8):900-917. PubMed ID: 28473526
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Renal Cell Carcinoma to the Pancreas: A Review.
Cheng SK; Chuah KL
Arch Pathol Lab Med; 2016 Jun; 140(6):598-602. PubMed ID: 27232353
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center.
Grassi P; Verzoni E; Mariani L; De Braud F; Coppa J; Mazzaferro V; Procopio G
Clin Genitourin Cancer; 2013 Dec; 11(4):484-8. PubMed ID: 23791435
[TBL] [Abstract][Full Text] [Related]
17. [Management of pancreatic metastases from renal cell carcinoma report of five cases].
Köhler K; Haroske G; Ludwig K
Zentralbl Chir; 2006 Oct; 131(5):425-8. PubMed ID: 17089295
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
Haeberle L; Busch M; Kirchner J; Fluegen G; Antoch G; Knoefel WT; Esposito I
J Med Case Rep; 2021 May; 15(1):314. PubMed ID: 34059139
[TBL] [Abstract][Full Text] [Related]
19. Curative-intent pancreas resection for pancreatic metastases: surgical and oncological results.
Chikhladze S; Lederer AK; Kühlbrey CM; Hipp J; Sick O; Fichtner-Feigl S; Wittel UA
Clin Exp Metastasis; 2020 Apr; 37(2):313-324. PubMed ID: 32095913
[TBL] [Abstract][Full Text] [Related]
20. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
